Skip to content
2000
Volume 20, Issue 25
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Peptidases can be inhibited by natural or synthetic small-molecule compounds, or by gene-encoded, proteinaceous inhibitors. Small-molecule peptidase inhibitors have been in the spotlight of researchers and pharmaceutical companies for many years. The studies concerning gene-encoded inhibitors are less frequent. The last decade has seen a boom of fungal genomics followed by extensive bioinformatic analyses focused particularly on those species that can cause infections in humans, animals or crops. Many sequences of putative inhibitors have been identified on the basis of homology with gene-encoded peptidase inhibitors of Saccharomyces cerevisiae, mammals or other organisms. However, characterization of the respective proteins is often missing. Gene-encoding peptidase inhibitors are rather diverse in size, mode of action, type of the target peptidase and localization. While some of the inhibitors are secreted to extracellular space and participate in host-pathogen interactions, others act intracellularly and their precise role in fungal physiology is not fully understood. However, most of the gene-encoded peptidase inhibitors are rather selective and efficient, and may be an inspiration for future directions of antimycotic research.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867311320250002
2013-08-01
2024-11-14
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867311320250002
Loading

  • Article Type:
    Research Article
Keyword(s): AFUEI; Avr2; cystatin; fungi; I2B; IA3; IAPs; inhibitor; pathogen; peptidase; programmed cell death; proteolysis; serpin; TFS1; yeast
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test